Downloadable Slideset

A Global Perspective on Emerging BTK Inhibitor Therapy Data for Relapsed/Refractory CLL and MCL in 2022*

2022 ASCO Annual Meeting, June 3-7, 2022, in Chicago, Illinois, USA; EHA 2022 Congress, June 9-12, 2022, in Vienna, Austria; 2022 Pan Pacific Lymphoma Conference, July 18-22, 2022, in Koloa, Hawaii, USA; ESMO 2022 Annual Congress, September 9-13, 2022, in Paris, France; 2022 SOHO Annual Meeting, September 28 - October 1, 2022, in Houston, Texas, USA

Get up to date on emerging data with BTK inhibitors for chronic lymphocytic leukemia and mantle cell lymphoma presented at the 2022 meetings of ASCO, EHA, Pan Pacific Lymphoma, ESMO, and SOHO with on-demand webcasts, expert podcasts, downloadable slides, commentaries, and a “year in review” module.

Othman Al-Sawaf, MD

Anthony Mato, MD, MSCE

Lydia Scarfò, MD

Julie M. Vose, MD, MBA

Downloadable Slideset

Slideset

A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL in 2022

View Slideset

Download this living slideset featuring new data from conference presentations on the use of BTK inhibitors to treat CLL and MCL. This slideset will be updated throughout 2022 and include key findings from the ASCO, EHA, Pan Pacific, ESMO, and SOHO annual meetings, so check back often.

Othman Al-Sawaf, MD

Anthony Mato, MD, MSCE

Lydia Scarfò, MD

Julie M. Vose, MD, MBA Released: October 10, 2022

A Global Perspective on Emerging BTK Inhibitor Therapy Data for Relapsed/Refractory CLL and MCL in 2022*

A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL in 2022

Leaving the CCO site